Boston Scientific (BSX) Competitors $104.30 +0.67 (+0.64%) Closing price 07/3/2025 03:59 PM EasternExtended Trading$104.30 0.00 (0.00%) As of 07/3/2025 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BSX vs. ALGN, HOLX, HQY, MMSI, AMN, DVA, ECL, HCA, ITGR, and MDTShould you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Align Technology (ALGN), Hologic (HOLX), HealthEquity (HQY), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), DaVita (DVA), Ecolab (ECL), HCA Healthcare (HCA), Integer (ITGR), and Medtronic (MDT). Boston Scientific vs. Its Competitors Align Technology Hologic HealthEquity Merit Medical Systems AMN Healthcare Services DaVita Ecolab HCA Healthcare Integer Medtronic Boston Scientific (NYSE:BSX) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment. Do analysts rate BSX or ALGN? Boston Scientific presently has a consensus price target of $116.09, indicating a potential upside of 11.31%. Align Technology has a consensus price target of $241.25, indicating a potential upside of 22.51%. Given Align Technology's higher probable upside, analysts plainly believe Align Technology is more favorable than Boston Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Boston Scientific 0 Sell rating(s) 0 Hold rating(s) 21 Buy rating(s) 3 Strong Buy rating(s) 3.13Align Technology 1 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.67 Do insiders and institutionals hold more shares of BSX or ALGN? 89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.5% of Boston Scientific shares are owned by insiders. Comparatively, 0.7% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media refer more to BSX or ALGN? In the previous week, Boston Scientific had 58 more articles in the media than Align Technology. MarketBeat recorded 78 mentions for Boston Scientific and 20 mentions for Align Technology. Align Technology's average media sentiment score of 1.29 beat Boston Scientific's score of 0.43 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 32 Very Positive mention(s) 7 Positive mention(s) 19 Neutral mention(s) 10 Negative mention(s) 9 Very Negative mention(s) Neutral Align Technology 15 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, BSX or ALGN? Boston Scientific has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.63, indicating that its stock price is 63% more volatile than the S&P 500. Which has better valuation and earnings, BSX or ALGN? Boston Scientific has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBoston Scientific$16.75B9.21$1.85B$1.3776.13Align Technology$4.00B3.57$421.36M$5.4935.87 Is BSX or ALGN more profitable? Boston Scientific has a net margin of 11.58% compared to Align Technology's net margin of 10.29%. Boston Scientific's return on equity of 18.67% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Boston Scientific11.58% 18.67% 10.38% Align Technology 10.29%13.52%8.36% SummaryBoston Scientific beats Align Technology on 12 of the 17 factors compared between the two stocks. Get Boston Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSX vs. The Competition Export to ExcelMetricBoston ScientificMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$154.34B$10.52B$5.56B$20.68BDividend YieldN/A2.07%5.24%3.71%P/E Ratio76.1317.0327.6628.10Price / Sales9.2129.59415.4138.21Price / Cash28.5822.9936.8922.53Price / Book6.993.668.034.58Net Income$1.85B$235.40M$3.18B$986.06M7 Day Performance-2.37%2.15%2.93%2.79%1 Month Performance1.58%3.38%3.75%5.46%1 Year Performance36.51%-10.18%35.20%15.06% Boston Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSXBoston Scientific4.6043 of 5 stars$104.30+0.6%$116.09+11.3%+37.0%$154.34B$16.75B76.1353,000Trending NewsInsider TradeALGNAlign Technology4.5514 of 5 stars$189.33+0.4%$241.25+27.4%-19.1%$13.72B$4.00B34.4920,945Positive NewsHOLXHologic4.8239 of 5 stars$65.16+0.2%$77.42+18.8%-11.9%$14.52B$4.03B27.497,063Positive NewsHQYHealthEquity3.6278 of 5 stars$104.76-0.1%$118.09+12.7%+19.1%$9.06B$1.20B76.473,120MMSIMerit Medical Systems4.3235 of 5 stars$93.480.0%$109.11+16.7%+9.0%$5.52B$1.36B45.827,400News CoverageAMNAMN Healthcare Services4.3063 of 5 stars$20.73-0.7%$32.08+54.8%-55.6%$793.54M$2.98B-4.792,968News CoverageAnalyst RevisionDVADaVita4.293 of 5 stars$142.40+0.5%$164.50+15.5%+3.3%$10.75B$12.82B14.1176,000Positive NewsECLEcolab4.8527 of 5 stars$269.59+0.8%$283.13+5.0%+16.3%$76.46B$15.74B36.6347,000Positive NewsAnalyst ForecastHCAHCA Healthcare4.8253 of 5 stars$383.21+1.0%$395.71+3.3%+14.2%$92.19B$70.60B17.04294,000Positive NewsAnalyst UpgradeITGRInteger3.6197 of 5 stars$122.92+0.3%$145.00+18.0%+5.2%$4.29B$1.75B58.2611,000MDTMedtronic4.8941 of 5 stars$87.25+1.4%$97.87+12.2%+14.7%$111.90B$33.54B24.1095,000Positive News Related Companies and Tools Related Companies Align Technology Alternatives Hologic Alternatives HealthEquity Alternatives Merit Medical Systems Alternatives AMN Healthcare Services Alternatives DaVita Alternatives Ecolab Alternatives HCA Healthcare Alternatives Integer Alternatives Medtronic Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BSX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
